Advertisement
U.S. markets open in 5 minutes

Intellia Therapeutics, Inc. (NTLA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
19.52+0.01 (+0.05%)
At close: 04:00PM EDT
19.61 +0.09 (+0.46%)
Pre-Market: 09:25AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close19.51
Open19.57
Bid19.51 x 200
Ask19.59 x 300
Day's Range19.30 - 19.92
52 Week Range17.09 - 34.87
Volume1,772,619
Avg. Volume1,434,667
Market Cap1.984B
Beta (5Y Monthly)1.76
PE Ratio (TTM)N/A
EPS (TTM)-5.48
Earnings DateNov 07, 2024 - Nov 11, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est67.58
  • GlobeNewswire

    Intellia Therapeutics Announces New Date for Upcoming Investor Webcast

    - Investor webcast to review the NTLA-2002 Phase 2 data is now planned for Thursday, October 24 at 8:30 a.m. ET CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced a new date for its upcoming investor webcast to review the data from the Phase 2 study of NTLA-2002. The webcast will now be held on Thursday, October 24 at 8:30 a.m.

  • GuruFocus.com

    Intellia Therapeutics Inc (NTLA) Q2 2024 Earnings Call Highlights: Strategic Advances and ...

    Intellia Therapeutics Inc (NTLA) showcases promising clinical progress and financial resilience amidst evolving market dynamics.